Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded”

As of the end of August, NCI has selected 1,891 competing awards for funding this fiscal year, all of which will be funded by the year’s end, NCI Director Anthony G. Letai said to the National Cancer Advisory Board.

September 18, 2026

Vol.52 No.34

By Claire Marie Porter

Cancer Policy

Letai shares weekly musings in NCI’s new “Tuesdays with Tony” series

This summer, NCI launched a weekly social media series hosted by Director Anthony Letai.

September 18, 2026

Vol.52 No.34

In Brief

Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research

Following a national search, NCI has selected Senthil K. Muthuswamy as the next director of the Center for Cancer Research. He assumed the role July 26.

September 18, 2026

Vol.52 No.34

In Brief

D. Neil Hayes to lead OSUCCC’s Institute for Precision Cancer Medicine

D. Neil Hayes, has been appointed director of the Institute for Precision Cancer Medicine, effective Sept. 14. Hayes will also serve as deputy director of the OSUCCC.

September 18, 2026

Vol.52 No.34

In Brief

UNC researchers receive $40M grant to use AI to help develop cancer vaccines

UNC Lineberger Comprehensive Cancer Center has received $40 million from the OpenAI Foundation, the non-profit parent organization that governs the for-profit company OpenAI Group PBC, to generate data that could make personalized cancer vaccines more effective.

September 18, 2026

Vol.52 No.34

Clinical Roundup

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain, UCLA-led review finds

Artificial intelligence may help radiologists identify subtle signs of breast cancers that are missed during routine mammograms—and some AI systems may even identify patterns associated with an increased risk of cancer before it becomes visible on a mammogram—but there are still many significant limitations, according to a review led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.

September 18, 2026

Vol.52 No.34

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

YOU MAY BE INTERESTED IN

Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded”

Letai shares weekly musings in NCI’s new “Tuesdays with Tony” series

Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research

D. Neil Hayes to lead OSUCCC’s Institute for Precision Cancer Medicine

UNC researchers receive $40M grant to use AI to help develop cancer vaccines

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain, UCLA-led review finds

Renew today!

Subscriber content

Never miss an issue!

Login

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

YOU MAY BE INTERESTED IN

Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI“To my knowledge, 100% of grants that clear my desk get funded”

Letai shares weekly musings in NCI’s new “Tuesdays with Tony” series

Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research

D. Neil Hayes to lead OSUCCC’s Institute for Precision Cancer Medicine

UNC researchers receive $40M grant to use AI to help develop cancer vaccines

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain, UCLA-led review finds

Never miss an issue!

Login

Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded”